Free Investing

Trader Mark submits:With the S&P 500 grasping at 1070, and yet another "90% day" as the student body has run back to the left ("risk off" stampede), let's take a look ahead at the key reports next week; both for the greater market and what we have our eyes on. The next three weeks are the heart of the earnings season, and some of our holdings begin to pop up next week.Names the market will focus on:Complete Story »

Equitymaster submits: Indian markets had a weak trading session today as the indices languished in the red throughout the day led by persistent selling across index heavyweights. While the BSE Sensex closed lower by around 48 points (down 0.3%), the NSE Nifty lost around 11 points (down 0.2%). Midcap and small cap stocks were not spared either as they closed lower by 0.3% and 0.2% respectively. Losses were largely seen in auto and oil & gas stocks. As regards global markets, most Asian indices closed in the red today. European indices have opened on a mixed note. The rupee was trading at Rs 44.36 to the dollar at the time of writing. Complete Story »

Sudhi Analyst submits:I think Dr. Reddy's Laboratories (RDY) presents an attractive reward/risk opportunity for investors with a 2-3 year horizon. Dr. Reddy's is on the cusp of major growth RDY fiscal 2010 sales are approximately $1.6 billion. RDY has guided towards a target of 25% ROE and $3 billion in sales by fiscal 2012. In order to get there, I looked for the earnings needed. I make the following assumptions:

• Net income Margin stays same around historical 13-14% sales
• ROE guidance for fiscal 2011 will be upped to 25%

Thus earnings during the 3 year period needed to achieve the goal would be approximately $1 Billion. See model here. Complete Story »

Equitymaster submits: After a weak opening, strong buying activity in the index heavyweights propelled the indices to stay well above the dotted line throughout the day. Although profit booking was witnessed at higher levels, the indices managed to hold on to their gains and close well into the positive. While the BSE Sensex closed higher by around 87 points (up 0.5%), the NSE Nifty gained around 23 points (up 0.4%). Midcap and smallcap stocks also registered gains of 0.6% each. While banking and auto stocks led the pack of gainers, healthcare and metals stocks were at the receiving end. As regards global markets, Asian indices closed mixed today while European indices have also opened on a mixed note. The rupee was trading at Rs 45.66 to the dollar at the time of writing. Complete Story »

Equitymaster submits: The Indian markets had a rather volatile session today. After oscillating to either side of yesterday's close for a larger part of the session, selling activity finally took toll pushing the indices into the red. There was no respite in the final trading hour as well and the markets closed well below the dotted line. While the BSE Sensex closed lower by around 75 points (down 0.4%), the NSE Nifty lost around 18 points (down 0.3%). The BSE Midcap closed flat, while the BSE Smallcap gained around 0.4%. Losses were seen in IT, banking and metals stocks. Barring India, most Asian indices closed in the green today while the European indices have opened on a mixed note. The rupee was trading at Rs 45.78 to the dollar at the time of writing. Complete Story »

Brooks McFeely submits:4:10 PM, Sep 11, 2009 --

• NYSE down 6.98 (0.1%) to 6,843.83.
• DJIA down 22 (0.23%) to 9,605.
• S&P 500 down 1.41 (0.14%) to 1,043.
• Nasdaq down 3.12 (0.2%) to 2,081.

GLOBAL SENTIMENT Complete Story »

Ryan Barnes submits:When you lose, Don’t lose the lesson - The Dalai Lama For the better part of 5 months I’ve been kicking myself over not dumping Pfizer (PFE) from the Secular Trends Portfolio the day they announced the Wyeth merger. The second I heard about the deal I honestly thought the TV announcer had made a mistake; “No no, it couldn’t be Wyeth. That would just be stupid”Complete Story »